Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ANPRB | P20594 | Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) | 1 | Immune mediationReceptor-signaling mediation | 7 | 0.50 | ||||
| BASI | P35613 | Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147) | Blood group antigen proteinsCD markersPredicted intracellular proteins | 1 | Graft-versus-host diseaseLiver cancerCOVID-19 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.50 | ||
| MOT4 | O15427 | Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediationImmune mediation | 7 | 0.50 | |||
| ODR4 | Q5SWX8 | Protein odr-4 homolog (hODR-4) (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1) | Predicted membrane proteins | 2 | Other mediation | 7 | 0.50 | |||
| PCDA1 | Q9Y5I3 | Protocadherin alpha-1 (PCDH-alpha-1) | Predicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediation | 7 | 0.50 | |||
| PCDBG | Q9NRJ7 | Protocadherin beta-16 (PCDH-beta-16) (Protocadherin-3X) | 1 | Adhesion and uptake mediation | 7 | 0.50 | ||||
| ROR2 | Q01974 | Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2) | 1 | Metastatic lymph node neoplasmRenal cell carcinoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 7 | 0.50 | |||
| S12A9 | Q9BXP2 | Solute carrier family 12 member 9 (Cation-chloride cotransporter 6) (hCCC6) (Cation-chloride cotransporter-interacting protein 1) (CCC-interacting protein 1) (hCIP1) (Potassium-chloride transporter 9) (WO3.3) | Predicted membrane proteinsTransporters | 12 | Fusion and delivery mediation | 7 | 0.50 | |||
| UFO | P30530 | Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) | Disease related genesEnzymesFDA approved drug targets | 1 | Acute myeloid leukaemiaBreast cancerKaposi sarcoma | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 7 | 0.50 | ||
| BACE1 | P56817 | Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Alzheimer disease | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 6 | 0.50 |